H. Masuyama et al., EVIDENCE FOR LIGAND-DEPENDENT INTRAMOLECULAR FOLDING OF THE AF-2 DOMAIN IN VITAMIN-D RECEPTOR-ACTIVATED TRANSCRIPTION AND COACTIVATOR INTERACTION, Molecular endocrinology, 11(10), 1997, pp. 1507-1517
A ligand-dependent transcriptional activation domain (AF-2) exists in
region E of the nuclear receptors. This highly conserved domain may co
ntact several coactivators that are putatively involved in nuclear rec
eptor-mediated transcription. In this study, a panel of vitamin D rece
ptor (VDR) AF-2 mutants was created to examine the importance of sever
al conserved residues in VDR-activated transcription. Two AF-2 mutants
(L417S and E420Q) exhibited normal ligand binding, heterodimerization
with retinoid X receptor, and vitamin D-responsive element interactio
n, but they were transcriptionally inactive in a VDR-responsive report
er gene assay. All AF-2 mutations that abolished VDR-mediated transact
ivation also eliminated interactions between VDR and several putative
coactivator proteins including suppressor of gall (SUG1), steroid horm
one receptor coactivator-1 (SRC-1), or receptor interacting protein (R
IP140), suggesting that coactivator interaction is important for AF-5-
mediated transcription. In support of this concept, the minimal AF-2 d
omain [VDR(408- 427] fused to the gal4 DNA binding domain was sufficie
nt to mediate transactivation as well as interaction with putative coa
ctivators. Introducing the L417S and E420Q mutations into the minimal
AF-2 domain abolished this autonomous transactivation and coactivator
interactions. Finally, we demonstrate that the minimal AF-2 domain int
eracted with an AF-2 deletion mutant of the VDR in a 1,25-(OH)(2)D-3-d
ependent manner, suggesting a ligand-induced intramolecular folding of
the VDR AF-2 domain. The L417S mutant of this domain disrupted the in
teraction with VDR ligand-binding domain, while the E420Q mutant did n
ot affect this interaction. These studies suggest that the conserved A
F-2 motif may mediate transactivation through ligand-dependent intermo
lecular interaction with coactivators and through ligand-induced intra
molecular contacts with the VDR ligand-binding domain itself.